A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
Harvard University · Dana-Farber Cancer Institute
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
697
total citations
- FWCI
- 19.71
- Percentile
- 100%
- References
- 43
Citations per year
Authors
18- DCDharminder ChauhanCorresponding
Harvard University, Dana-Farber Cancer Institute
- LCLaurence Catley
Harvard University, Dana-Farber Cancer Institute
- GLGuilan Li
Harvard University, Dana-Farber Cancer Institute
- KPKlaus Podar
Harvard University, Dana-Farber Cancer Institute
- THTeru Hideshima
Harvard University, Dana-Farber Cancer Institute
Topics & keywords
Topics
Keywords
- Bortezomib
- Multiple myeloma
- Proteasome inhibitor
- Proteasome
- Apoptosis
- Cancer research
- Orally active
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.